Skip to main navigation
Skip to search
Skip to main content
Ariel University Home
Help & FAQ
Link opens in a new tab
English
עברית
العربية
Search content at Ariel University
Home
Profiles
Research units
Equipment
Research output
Prizes
Activities
Press/Media
Motherisk update: Cancer chemotherapy during pregnancy
M. Lishner
, G. Koren
Department of Medicine
Research output
:
Contribution to journal
›
Review article
›
peer-review
8
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Motherisk update: Cancer chemotherapy during pregnancy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Motherisk
100%
Chemotherapy
100%
Second Trimester
100%
Cancer Chemotherapy
100%
Major Congenital Malformations
100%
Chemotherapy in Pregnancy
100%
First Trimester
50%
Fetus
50%
During Pregnancy
50%
Third Trimester
50%
Pregnant Women
50%
Low Birth Weight
50%
Pregnancy Trimester
50%
Oncologists
50%
Hodgkin Disease
50%
Chemotherapy Effect
50%
Medicine and Dentistry
Motherisk
100%
Cancer Chemotherapy
100%
Chemotherapy
100%
First Trimester Pregnancy
66%
Congenital Malformation
66%
Second Trimester Pregnancy
66%
Low Birth Weight
33%
Third Trimester Pregnancy
33%
Oncologist
33%
Hodgkin's Lymphoma
33%
Pharmacology, Toxicology and Pharmaceutical Science
Cancer Chemotherapy
100%
Chemotherapy Regimens
100%
Congenital Malformation
66%
Low Birth Weight
33%
Hodgkin Disease
33%